Business intelligence reports for the lab diagnostics industry
Subscribe for Exclusive Access.
Subscriptions & Reports
Interested in multiple copies or more than one of our G2 reports?
Call Sokha at 855-528-6903 or email spearson@g2intelligence.com to discuss pricing.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
One-Step HCV RNA Tests Help Encourage Hepatitis C Screening
...
Agency Continues Crack Down on Unauthorized COVID-19 Tests
On Jan. 11, the FDA warned consumers not to use COVID-19 tests from LuSys Laboratories, as they have not been approved for use in the US.
FDA Points the Way to Transition EUA SARS-CoV-2 Tests to Full Approval
...
New Blood Test Enables Early Cancer Detection in “Low-Risk, but Not No-Risk” Patients
...
COVID-19 Testing Drives Increase in Part B Medicare Lab Spending
Here’s a look at the key takeaways from the Dec. 30 OIG report on Medicare Part B spending on lab testing.
Theranos Wunderkind Elizabeth Holmes Convicted on Federal Fraud Charges
...
Federal Enforcers Crack Down on Fraudulent Billing of Genetic Tests
Labs that bill federal health care programs for these tests need to pay especially close attention to ensure compliance.
The Sun Is About to Set on the Controversial Trump Era “SUNSET” Rule
...
Omicron Forces FDA to Temporarily Shut Down Inspections
...
White House Ups Effort to Resolve Rapid, At-Home COVID-19 Test Shortages
...
